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Abstract. Many joint-SNVs (single-nucleotide variants) analysis methods were 
proposed to tackle the ‘missing heritability’ problem, which emphasizes that the 
joint genetic variants can explain more heritability of traits and diseases. 
However, there is still lack of a systematic comparison and investigation on the 
relative strengths and weaknesses of these methods. In this paper, we evaluated 
their performance on extensive simulated data generated by varying sample size, 
linkage disequilibrium (LD), odds ratios (OR), and minor allele frequency 
(MAF), which aims to cover almost all scenarios encountered in practical 
applications. Results indicated that a method called Statistics-space Boundary 
Based Test (S-space BBT) showed stronger detection power than other methods. 
Results on a real dataset of gastric cancer for Korean population also validate 
the effectiveness of the S-space BBT method. 
Keywords: GWAS; Sequence analysis; Joint-SNVs analysis test; Statistics-
space Boundary based test; gastric cancer  
1 Introduction 
The GWAS has made tremendous success based on the hypothesis ‘Common Disease, 
Common Variant (CDCV)’ [1], yet common variants identified via the GWAS only 
explained a small fraction of the heritability factors owing to two aspects. First, the 
traditional GWAS only focuses on the common variants to the common diseases, 
while the rare variants also make contributions to the common diseases in the light of 
‘Common Disease, Rare Variant (CDRV)’ [2], and it is defined through the MAF ( 
≤ MAF ≤ 5); second, it aims to detect the single genetic variants to the diseases 
while neglects the combined effect of SNVs [3]. The ‘next generation’ sequencing 
technologies facilitate the detection for rare variants contributing to the complex 
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diseases. However, interesting rare variants have difficulty in being captured owing to 
the insufficient sample size. 
In view of this, investigators have proposed many joint-SNVs analysis methods to 
solve them. These methods can be divided into three categories via the way to 
obtaining the corresponding statistics. The first road is the ‘projection’. We transform 
the statistics vector into one statistic for simplified calculation of P-value. Thus, it is 
crucial to define suitable ‘projection’ matrix. For instance, the Hotelling’s T square 
test transforms the difference of mean vectors for two populations into the Hotelling’s 
T square statistic by multiplying the inverse of covariance matrix. However, accurate 
estimation of the covariance matrix depends on the large sample size and the low 
missing rate. On the basis of CDRV, some methods collapse or sum up all SNVs in a 
unit into a single one to discover the accumulation effect of rare variants. Here, the 
‘projection’ matrix is diagonal. These methods can be divided into two groups 
according to whether the ‘projection’ matrix is the identity matrix or not. The two 
groups are named after burden test and non-burden test. The burden test assumes that 
SNVs contribute to the unit equally, while the non-burden test does not. The second is 
the ‘combination’ in the probability space [4]. The Fisher’s method combined the P-
value of each hypothesis into the Chi-square statistic in linear form, but much 
information is lost. And the third road is that we perform the multivariate test in the 
high dimensional space directly, so that it can break through the two limitations that 
the existing methods suffered from [5]. First, these existing methods regardless of the 
relationship between the dimensions; Second, the direction for each component is not 
taken into consideration. It is of note that S-space BBT is the representative method in 
the third road, and the comparative study involved it is still absent both in the large-
scale simulation dataset and real-world dataset.  
In this paper, we first introduced six representative methods, and then performed 
the comparative study in considering the varying sample size, OR, LD and MAF. The 
simulation results showed that (1) all the involved methods obtain stronger detection 
power with the sample size increasing. S-space BBT and SKATO are more sensitive 
than other four methods; (2) S-space BBT has stronger detection power than other 
methods under different OR, LD and MAF; (3) S-space BBT almost obtains smaller 
P-value compared with other methods in the real-world datasets. All above indicate 
that the S-space BBT plays an important role for joint-SNVs analysis. Thus, we 
applied it to a dataset of gastric cancer for Korean population and obtained a 
susceptibility gene list. The literature survey for selected genes was conducted to 
validate the effectiveness of S-space BBT. As a result, we provided the biomarker list 
and anticipated that it can be the reference for the gastric cancer study. 
2   Representative Methods 
2.1   Hotelling’s T Square Test 
The Hotelling’s T square distribution is the generalization of the Student’s t-
distribution. Given two populations and they follow the independent multivariate 
normal distributions with same mean and covariance. The Hotelling’s T square 
statistic is defined as: 
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where the m and n are the size of two populations, p is the number of variates, x~  
and y~ are the sample means and the ˆ indicates the covariance matrix. In order to 
calculate the P-value, we often transform it into F statistics. 
As for the case-control study, the Hotelling’s T square test obtains more accurate 
P-value when the sample size is large and the missing rate for genotype data is low, 
because both lead to the precise estimation for the covariance matrix. 
2.2   Sumstat Test 
The sumstat test, one kind of the burden test, treats the SNVs equally in the unit and 
adds all of the statistics from each SNV together to conduct the hypothesis test. It can 
enhance the power in considering the existence of rare variants. But it ignores the 
effect direction and the magnitude effect of SNVs. When the SNVs have same effect 
direction and the magnitude, the sumstat test obtained the better performance. The 
effect direction is defined via the OR, when the OR > 1, the direction is deleterious, 
otherwise, the direction is protective. 
2.3   The Sequence Kernel Association Test (SKAT) and its Optimal Version 
For the regression model, we test whether the unit has influence on phenotype under 
the null hypothesis as described in the Eq.(1).  
  (2) 
where the  indicates the coefficients vector and the null hypothesis means that the 
corresponding SNV is not associated with the phenotype. The SKAT assumes each j 
follows an arbitrary distribution with a mean of zero and a variance of wj and then 
tests the null hypothesis H0:where the wjis the prespecified weight. It obtains 
the variance-component score statistics which take the direction of into 
consideration. 
  The optimal version of SKAT (SKATO) [6] combined burden statistic Qburden and 
SKAT statistic QSKAT into the SKATO statistic Q in linear form. SKATO statistic is 
described as followed: 
Q = QSKAT Qburden (3) 
where  indicates pair-wise correlation among jin Eq.(1). 
  Both of them belong to the non-burden test, not only taking the effect direction into 
account but also the magnitude of effect. So compared with the burden test, they are 
more robust. 
2.4   Fisher’s Combined Test 
The Fisher’s combined test combines the P-value from each test into the Chi-square 
statistic assuming the hypotheses are independent. The formula is defined as: 
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where the k is the number of the hypotheses and the pi is the P-value obtained from 
the i-th hypothesis. 
  It suffers from the poor performance in joint-SNVs analysis owing to the 
information loss (e.g., LD, effect direction and so on). If there are many causal 
variants in the unit, the Fisher’s combined method can achieve better performance. 
2.5   Statistic-space Boundary Based Test 
The above tests reject the H0 as long as at least one of dimensions is rejected, and they 
ignore the roles of dimensions and their combination just as described in the Fig 3(a) 
of [5]. The S-space BBT is one of the directional test and is described in the Fig 6(a) 
of [5]. The way to achieving the combination is also given in Eq.(13)-(19) of [5]. 
  The implementation of S-space BBT has been described in details in the Tab. 6 of 
[4]. Here, we give some key points of it. First, we directly use the boundary to form 
the rejection domain in the statistic space as followed: 
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calculated by the permutation test (see (65) in [4]). Third, the principle component 
analysis is performed to remove the second-order dependence. Forth, we adopt the 
posteriori version of the P-value for reduction of the background disturbance (see 
(93) of in [4]). 
  We have analyzed the application scenarios for the six methods in theory. The 
related computation have shown three points in the [7]. First, the six methods except 
for the S-space BBT swamp the significant SNVs. Second, burden test is powerful 
under the same effect direction. While the SKAT/SKATO is suitable for the 
different effect direction. Third, S-space BBT has stronger detection power in 
different MAF, LD and OR. In this paper, we adopted the statistic power to evaluate 
the six methods under the sample size, LD, OR and MAF in the simulation 
experiments. The detection power is defined as the proportion of true positive results. 
They were also evaluated on the real-world datasets. 
3   Simulation Experiments 
3.1   Simulation Framework 
In order to compare the power of different approaches under various conditions, we 
use the simulation tool of PLINK software [8] to generate large simulation datasets. 
The number of SNVs in the joint unit is 10, which is composed of 5 causal variants 
and corresponding 5 observed markers. As a result, we obtained the simulation data of 
10 SNVs on 100 cases vs. 100 controls, 500 cases vs. 500 controls and 1000 cases vs. 
1000 controls in a stochastic way. Other parameter settings for the simulation datasets 
were described in the Table 1. Note that the LD in the Table 1 is calculated between 
causal variant and corresponding observed marker, so we call it the incomplete LD. 
Besides, we produced 1000 replicates for each dataset for power computation and set 
the threshold 0.05. In the [9], the detection power was estimated as the proportion 
of P-value ≤  among the 1000 replicates. 
Hotelling’s T square test, Fisher’s combined test and S-space BBT were 
implemented by the MATLAB. We adopted the SKATBinary function in the SKAT 
package of the R software to perform SKAT and SKATO. Sumstat test was 
performed by the PLINK/seq software with 100000 times of permutation. 
Table 1.  Parameter settings for simulation datasets 
Conditions DatasetID ORhet ORhom MAF Marker / causal variant LD 
LD 
Dataset1 1.2 2.4 0.05 0.4 
Dataset2 1.2 2.4 0.05 0.96 
OR 
Dataset3 1.1 2.2 0.05 0.8 
Dataset4 1.2 2.4 0.05 0.8 
Dataset5 1.3 2.6 0.05 0.8 
MAF 
Dataset6 1.2 2.4 0.01 0.8 
Dataset7 1.2 2.4 0.03 0.8 
Note: ORhet indicates the odds ratio for heterozygote causal variants. 
ORhom indicates the odds ratio for homozygote causal variants. 
3.2   Simulation Results 
3.2.1   Linkage Disequilibrium 
We first focus on the effect of the incomplete LD on each method. The linkage 
disequilibrium is the correlation between two SNVs and can be measured with the 
correlation coefficient [10]. The results were shown in the Fig. 1. 
  All of the methods achieved higher detection power with the sample size 
increasing. In particularly, the accurate estimation of the covariance matrix may 
account for the improvement for Hotelling’s T square test, SKAT and SKATO. The 
S-space BBT obtained the best performance among the six methods. The SKATO 
obtained stronger detection power than sumstat test and SKAT. In conclusion, the 
power of the six methods is almost constant in different incomplete LD. 
3.2.2   Odds Ratio 
The odds ratio is utilized to quantify the relationship between property A and 
property B in a given population. In GWAS, it quantifies the impact that one allele 
has on disease. When the OR > 1, the SNV is defined as deleterious one, which 
means that the more frequent the allele of SNV appears, the more likely to get sick. 
Conversely, when the OR < 1, the SNV is defined as protective one.  
  As shown in the Fig. 2, the power for each method enhances as the OR increasing, 
and SKATO is more sensitive than other methods. The sensitivity indicates the 
growth rate of detection power under different conditions. When the OR is large 
enough and the sample size is 2000, all methods achieved at least 85% power. The 
S-space BBT still keep the highest power in the different OR. 
 
 
Fig. 1. Power comparison under different incomplete LD 
 
Fig. 2. Power comparison under different OR 
3.2.3   Minor Allele Frequency 
One site has two alleles (e.g. ‘A’ and ‘a’) in general. The frequency of second most 
common allele is the minor allele frequency in a given population. The rare variants 
are defined by the minor allele frequency. Based on the CDRV, the rare variants 
play a crucial role in genetic susceptibility to common diseases [2]. 
As described in the Fig. 3, all the six methods obtained stronger power with the 
MAF increasing, and each achieved greater sensitivity. It is of note that the S-space 
BBT kept the better performance (poweraverage ≥ 60%) when the MAF = 1%, while 
other methods achieved less than 20% average power. The Fisher’s combined 
method achieved 0.2% power when the sample size is 100 vs. 100 and the MAF = 
1%. 
 
Fig. 3. Power comparison under different MAF 
4   Gastric Cancer Study 
4.1   Quality Control 
The gastric cancer is the fifth most common malignancy in the world, especially in 
the Korea [11]. The selected dataset is associated with the gastric cancer for Korean 
population from the GEO database (Gene Expression Omnibus, ID: GSE58356). 
319283 probes make up the dataset with the sample size of 683 controls and 329 
cases. 
  As for the quality control, we took the Hardy-Weinberg's equilibrium and the 
missing rate into consideration. The Hardy-Weinberg law states that the allele and 
genotype frequency in a population will remain constant generation after generation. 
It is essential to regard the Hardy-Weinberg's equilibrium as one of measures in the 
quality control owing to the identification of questionable genotypes [12]. The 
threshold of the missing rate is set to 5, and the threshold of the Hardy-Weinberg's 
equilibrium is set to 1.00E-04. After quality control and removing the duplicate 
probes, 54988 SNVs were remained. We regarded the gene as a unit and obtained 
14709 units to conduct the joint-SNVs analysis via the S-space BBT. 
4.2   Evaluation on the Real-world Dataset 
To overcome some limitations (e.g., the LD, existence of the causal variants and so 
on) of the simulation experiments, we made efforts to search for the SNVs that are 
not only generally recognized but also can be found in the published SNVs datasets. 
Finally, 3 significant SNVs were found. Then all the six methods were performed for 
them and the results were shown in the Table 2. 
Table 2.  Results of three benchmarks for the six methods 
Gene SBBT Hot Fis SKAT SKATO SUM 
PSCA 8.90E-10 1.23E-06 1.65E-12 4.49E-01 4.49E-01 1.30E-03 
ANK3 5.62E-08 4.83E-04 5.66E-03 7.43E-02 1.09E-01 6.85E-03 
PALB2 7.96E-07 2.09E-03 1.13E-03 3.04E-01 3.28E-01 5.35E-03 
Note: Hot indicates the Hotelling’s T square tests; Fis means the Fisher’s combined test; SUM 
indicates the sumstat test. 
 
The well-known rs2294008 in PSCA (prostate stem cell antigen) [13,14] is 
involved in the GSE58356 dataset, so that it can be the benchmark for comparative 
study. It was also identified in our gastric cancer study (P-value = 1.12E-07, OR = 
1.66). In our dataset, the PSCA contains three SNVs, so the Hotelling’s T square test 
obtained better performance. There is other SNV (rs1045531) whose P-value is 
7.73E-08 in the PSCA, which leads to the small P-value for Fisher’s combined 
method. S-space BBT and Fisher’s combined method maintained the significance of 
the causal variant (rs2294008) while others did not. 
The rs1938526 and rs420259 are found in the GSE71443 dataset consisting of 65 
bipolar disorder patients and 74 controls. The dataset contains no missing value. We 
adopted similar quality control as the GSE58356 did.  
The rs1938526 of the ANK3 (Ankyrin 3) is the susceptibility locus for the bipolar 
disorder in [15]. For the ANK3, there are 235 SNVs involved, which may result in 
the inaccuracy computation of joint P-values owing to the small size of population. 
Thus, we selected SNVs located in the upstream and downstream 20kb of rs1938526 
to make up the computational unit, and 15 SNVs were remained. The smallest single 
locus P-value is 1.21E-05, while the P-value of rs1938526 ranks second (P-value = 
0.06, OR = 1.58). The Hotelling’s T square test obtained the smaller P-value 
compared to the other methods except for the S-space BBT owing to no missing 
value. 
The rs420259 in PALB2 (Partner And Localizer Of BRCA2) is also regarded as 
the meaningful SNV for the bipolar disorder [16]. For the PALB2, three SNVs are 
involved in. The rs420259 has the smallest P-value (P-value = 2.95E-03, OR = 0.42). 
Fisher’s method, Hotelling’s T square test and sumstat test achieved similar P-value. 
In conclusion, the S-space BBT achieved smaller P-value compared with other 
methods for the ANK3 and PALB2. As for the PSCA, the P-value of S-space BBT is 
also significant (pSBBT ≤ 2.50E-06). The SKAT and the SKATO performed worst for 
the three genes, which might result from the small sample size.  
4.3   Literature Survey for Top 20 Associated Genes of Gastric Cancer 
It is of note that we mainly focus on the combined effect of SNVs in the comparative 
study. Thus, some genes would be neglected owing to two points. First, smallest P-
values of SNVs in these genes are smaller than 5.00E-08, which indicates that the 
traditional GWAS can detect them; second, there is only one SNV in the gene. Then, 
we selected top 20 genes detected via S-space BBT to conduct the literature survey. 
The search result was shown in the Appendix in detail. Further, we divided the 
genes into three groups. C group means those genes related to gastric cancer, B 
group indicates those related to other kinds of cancers and A group is other cases. In 
summary, there are 65% genes associated with the gastric cancer and other kinds of 
cancers. It indicates that the S-space BBT is reliable in the joint-SNVs analysis. 
5   Conclusion 
We conducted a comparative study on the main threads of joint-SNVs analysis 
methods in considering the sample size, LD, OR and MAF. The simulation 
experiments were designed to show that the S-space BBT has stronger detection 
power compared with other involved methods in different conditions. The simulation 
results showed that the S-space BBT plays an crucial role in detection of the 
susceptibility genes. More generally, we evaluated them on the real-world dataset 
and reached the same conclusion. Thus, we applied the S-space BBT to the dataset 
of gastric cancer for Korean population and obtained 20 significant genes. In order 
to validate the efficiency of the S-space BBT, we conducted literature survey for the 
top 20 genes, of which 65% are associated with the gastric cancer and other kinds of 
cancers. The prevalence of many diseases is low, which leads to the sample 
disequilibrium problem in statistical tests. The reactions of different joint-SNVs 
analysis methods to the problem might be an interesting issue, further, it is essential 
for investigators to propose novel methods to solve it. 
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